| |
 |
SYM |
Description |
|
|
Private |
Therapeutic delivery systems and imaging agents for the identification and treatment of cancer and cardiovascular disease |
 |
|
|
|
|
|
|
|
Private |
Small molecule therapeutics for the treatment of prostate cancer |
|
|
|
|
|
|
|
|
Private |
Clinical research services focused on oncology. |
|
|
|
|
|
|
 |
|
private |
Diagnostic laboratory services for advanced molecular support in indeterminate oncology cases |
|
|
|
|
|
|
|
|
ABBI |
Oncology, anti-infective and critical care injectable pharmaceuticals. |
|
|
|
|
|
|
|
|
PARD |
Developing a new generation of oncology products for the treatment of small cell lung, colorectal and hormone- refractory prostate cancers |
|
|
|
|
|
|
|
|
Private |
Oncology drug development. |
|
|
|
|
|
|
|
|
Private |
Advanced radiation treatment therapies. |
|
|
|
|
|
|
|
|
Private |
Drug discovery in the areas of oncology, CNS, cardiovascular disease, immunology, and internal medicine. |
|
|
|
|
|
|
|
Pharminox |
|
Steventon, Abingdon, |
United Kingdom |
|
Private |
Small molecule oncology research and development. |
|
|
|
|
|
|
|
|
Private |
Outpatient radiation oncology care and management services for physicians and hospitals. |
|
|
|
|
|
|
|
|
Private |
Molecular oncology testing services for the care and management of cancer patients. |
|
|
|
|
|
|
|
|
Private |
Drug discovery and development in the field of oncology. |
|
|
|
|
|
|
|
|
Private |
Studies of anticancer agents. |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical candidates for oncology and women's health applications. |
|
|
|
|
|
|
|
|
Private |
Contract research for oncology, CNS, and respiratory and infectious disease. |
|
|
|
|
|
|
|
|
Private |
Products in the areas of anti-infectives, obesity and oncology. |
|
|
|
|
|
|
|
|
GENZ |
Cancer vaccines, angiogenesis inhibitors, and cancer pathway regulators. |
|
|
|
|
|
|
|
|
Private |
Products for neurology, genetic disorders, haematology, nephrology, oncology and rheumatolgy. |
|
|
|
|
|
|
|
|
Private |
Contract research organization for clinical trials in oncology, neurology and diabetology. |
|
|
|
|
|
|
|
|
Private |
Developing drug candidates with institutions in the field of medical oncology. |
|
|
|
|
|
|
|
|
Private |
Reagents for in vitro diagnostics in the fields of infectious diseases, endocrinology, oncology, and autoimmunity. |
|
|
|
|
|
|
|
CAC |
|
Le Kremlin-Bicêtre Cedex, |
France |
|
Private |
Research on oncology and development of agent and regimens for patients. |
|
|
|
|
|
|
|
|
Private |
Contract hematology/oncology expertise for the pharmaceutical industry |
|
|
|
|
|
|
|
|
Private |
Novel drug-delivery strategies for the field of oncology. |
|
|
|
|
|
|
|
|
Private |
Emerging technologies in the life and physical sciences with a focus on oncology. |
|
|
|
|
|
|
|
|
Private |
Drug delivery systems for hypoparathyroidism, diabetes, oncology and neurodegeneration. |
|
|
|
|
|
|
|
|
Private |
Pharmaceuticals for oncology, endocrinology, and neuromuscular disorders. |
|
|
|
|
|
|
|
|
Private |
Specialy pharmaceuticals for oncology, urology and neurology |
|
|
|
|
|
|
|
|
Private |
Contract research for cns disorders and oncology. |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
